Why Infusion Centers Are Leaving Revenue on the Table

An infusion chair only earns revenue when the right patient, the right drug, and a confirmed authorization line up at the same time. Today, that alignment breaks down constantly, and the cost shows up as underutilization rather than a labeled loss on anyone's P&L.

• Why PA delays, not staffing gaps, are the real bottleneck in infusion scheduling
• The three places revenue actually disappears: chair utilization, drug waste, and delayed patient access
• Why PA status, drug availability, and chair capacity typically live in three or four disconnected systems, and what changes when they don't
• What a unified, real-time view of authorization and capacity does for scheduling accuracy and clinical team time.

See how Gravity brings PA status, drug availability, and chair capacity into one view for infusion operations.